secwatch.observer — SEC 8-K summary
======================================

Issuer:     PDS Biotechnology Corp (PDSB)
CIK:        0001472091
Form:       8-K
Filed at:   2024-08-05T23:59:59+00:00
Accession:  0001140361-24-035618
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PDS Biotech VERSATILE-002 abstract accepted for ESMO 2024 presentation
----------------------------------------------------------------------

- Abstract on first-line Versamune HPV + KEYTRUDA in HPV16-positive recurrent/metastatic HNSCC accepted for ESMO.
- Poster number 879P; session at ESMO Congress 2024 in Barcelona, Sept 13-17.
- Presenting author: Dr. Jared Weiss, Section Chief at UNC and trial PI.
- Poster title includes survival data; no clinical results disclosed in this release.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1472091/000114036124035618/0001140361-24-035618-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1472091/000114036124035618/ef20033543_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-035618

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer